Clinical trial
BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory…
NCT00028561 · National Cancer Institute (NCI), NIH · Terminated
Key facts
| NCT number | NCT00028561 |
|---|---|
| Title | BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors |
| Official title | A Phase I Study of Epothilone B Analog BMS 247550 in Combination With Carboplatin in Recurrent and/or Refractory Solid Tumors |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug, Other |
| Interventions | ixabepilone, carboplatin, laboratory biomarker analysis, pharmacological study |
| Enrollment | 45 |
| Start date | Oct 1, 2001 |
| Primary completion | Feb 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 17, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: